Cargando…
Inhibition of HEV Replication by FDA-Approved RdRp Inhibitors
[Image: see text] Hepatitis E virus (HEV) is primarily a hepatotropic virus that is responsible for acute hepatitis E in the general population and for chronic hepatitis in immunocompromised individuals. In the absence of a globally accessible vaccine, pegylated interferon-α and ribavirin are the on...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2023
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633873/ https://www.ncbi.nlm.nih.gov/pubmed/37969986 http://dx.doi.org/10.1021/acsomega.3c05637 |